FECAVA - Federation of European Companion Animal Veterinary Associations

FECAVA - Federation of European Companion Animal Veterinary Associations Improving Veterinary Care for Europe's Companion Animals

🎙️ Meet the Speaker | FECAVA Certificate in Small Animal Anaesthesia and AnalgesiaWe are delighted to introduce Paulo St...
19/08/2026

🎙️ Meet the Speaker | FECAVA Certificate in Small Animal Anaesthesia and Analgesia

We are delighted to introduce Paulo Steagall (MV, MS, PhD, DACVAA), Professor of Veterinary Anaesthesia and Analgesia at City University of Hong Kong and Scientific Academic Advisor of the FECAVA Certification.

Dr. Steagall is an internationally recognised expert in feline welfare and pain management, co-chair of the WSAVA Pain Committee, and the creator of the Feline Grimace Scale. He has published over 150 scientific articles and the book Feline Anesthesia and Pain Management.

📚 Modules I–III
Topics:
• Pre-anaesthetic Assessment and Patient Preparation
• Acute Pain Recognition and Assessment
• The Feline Grimace Scale
• Principles of Acute Pain Management
• Premedication, Sedation and Oligoanalgesia
• Feline Anaesthesia Challenges
• Euthanasia

💬 Join Dr. Steagall as he explores practical, evidence-based approaches to anaesthesia, acute pain management, and feline welfare.

📝 Registration is now open!
🔗 Register here: https://www.fecava.org/fecava-certificate-in-small-animal-anaesthesia-and-analgesia/

FECAVA Monday Read | Hemoperfusion for Veterinary Toxicities: IRIS Best Practice GuidelinesA new 2026 consensus guidelin...
17/08/2026

FECAVA Monday Read | Hemoperfusion for Veterinary Toxicities: IRIS Best Practice Guidelines

A new 2026 consensus guideline from the International Renal Interest Society (IRIS) Hemoperfusion Study Group provides practical recommendations for the use of hemoperfusion in veterinary patients with toxin exposures and life-threatening intoxications.

Hemoperfusion, or hemoadsorption, uses a sorbent-based device to remove toxins and other target substances from the blood. The guidelines highlight that early treatment may be particularly important, especially when a toxin is amenable to removal, is likely to cause organ injury, and no effective antidote is available.

At the same time, hemoperfusion is not recommended for every suspected exposure. In stable animals with mild, non-progressive signs and an uncertain intoxication, conventional supportive care is generally preferred.

The authors note that current evidence remains limited and inconsistent, so the recommendations rely heavily on expert consensus. As hemoadsorption technologies and clinical experience continue to develop, these guidelines are expected to evolve.

This review highlights the growing role of extracorporeal therapies in veterinary emergency and critical care and the importance of selecting the right patient, toxin and timing for treatment.

Read the full article here: https://www.sciencedirect.com/science/article/pii/S1090023325002230?via%3Dihub

Still thinking about applying for the FECAVA Laboklin Travel Scholarship? Let our 2025 winner, Dr. vet. med. Tanja Striš...
16/08/2026

Still thinking about applying for the FECAVA Laboklin Travel Scholarship?
Let our 2025 winner, Dr. vet. med. Tanja Strišković, inspire you!

With the scholarship, Tanja was able to participate in the SkillVet Intensive Veterinary Cardiology course, travelling to 4 different European countries over 8 months.

💬 In Tanja’s own words:

“FECAVA Laboklin Travel Scholarship has enabled me to participate in the most amazing Cardiology course.
Considering the cost of traveling multiple times to different European countries, food and accommodation, this would have been much more difficult without this amazing scholarship.
Thank you FECAVA and Laboklin for this opportunity and for helping me become a better veterinarian and cardiologist.”

Your opportunity could be next. ✈️🐾

Every year, 2 European veterinarians receive €1,000 towards travel for a conference, specialist centre, or visit to a colleague in another European country.

📅 Deadline: 18 August 2026 - only 2 days left!
Apply now: https://www.fecava.org/schoolarships/

The Regulation (EU) 2026/1818 on the welfare and traceability of dogs and cats was published in the Official Journal of ...
14/08/2026

The Regulation (EU) 2026/1818 on the welfare and traceability of dogs and cats was published in the Official Journal of the EU on 10 August 2026, marking the completion of the legislative process.

The new Regulation introduces harmonised EU rules on:

➡️ Identification & registration of dogs and cats
➡️ Interoperable databases for improved traceability
➡️ Online selling & advertising
➡️ Welfare standards for breeding establishments
➡️ Requirements for breeders, including training and veterinary oversight

Together with FVE, FECAVA has prepared a leaflet, What’s New in the Regulation?, providing a quick overview of the key changes for veterinarians, breeders, establishments, and owners.

The Regulation is an important step towards better welfare, transparency and traceability, but effective implementation and practical guidance for frontline veterinarians will be essential. 🇪🇺

📄 Read the leaflet:https://fve.org/cms/wp-content/uploads/Dogs-and-Cats-brochure-9.pdf

⏰ 5 DAYS LEFT TO APPLY! ✈️🐾Dreaming of taking your veterinary journey beyond your own country? The FECAVA Laboklin Trave...
13/08/2026

⏰ 5 DAYS LEFT TO APPLY! ✈️🐾

Dreaming of taking your veterinary journey beyond your own country?

The FECAVA Laboklin Travel Scholarship could help make it happen! Every year, 2 European veterinarians receive €1,000 to support travel to a conference, specialist centre, or colleague in another European country. 🇪🇺

✨ How to apply?
Simply send:
🎥 A 30–60 second video about yourself and your travel plans
📄 Proof that you are a European veterinarian

📅 Deadline: 18 August 2026
📩 Submit your application to: [email protected]

The scholarship recipients will be announced at the WSAVA–PSAVA–FECAVA World Congress 2026.

So… what are you waiting for? Your next veterinary adventure could be just one application away! 🐶🐱

🎓 THE FECAVA CERTIFICATE IN SMALL ANIMAL ANAESTHESIA & ANALGESIAWhat does it actually change in practice?🩺 Safer anaesth...
11/08/2026

🎓 THE FECAVA CERTIFICATE IN SMALL ANIMAL ANAESTHESIA & ANALGESIA

What does it actually change in practice?

🩺 Safer anaesthesia
💊 Smarter pain management
🔎 More confident regional techniques
🧠 Stronger clinical decision-making

99% apply what they learn.

Because great education should make a difference where it matters most in practice. 🐾

👉 Ready to take your practice further?
Click the link to register: https://www.fecava.org/fecava-certificate-in-small-animal-anaesthesia-and-analgesia/

A significant step forward for the welfare of dogs and cats across Europe! 🇪🇺FECAVA welcomes the new EU Regulation on th...
10/08/2026

A significant step forward for the welfare of dogs and cats across Europe! 🇪🇺

FECAVA welcomes the new EU Regulation on the welfare and traceability of dogs and cats. Stronger welfare standards, better traceability and greater responsibility are important steps towards improving the lives of companion animals across Europe.

We’re pleased to share this useful overview of what’s new in the Regulation: https://shorturl.at/SIhAI

FECAVA Monday Read | Oral F***l Microbiota Transplantation in Dogs with Chronic EnteropathyA recent 2026 study investiga...
10/08/2026

FECAVA Monday Read | Oral F***l Microbiota Transplantation in Dogs with Chronic Enteropathy

A recent 2026 study investigated whether oral f***l microbiota transplantation (FMT) could improve clinical outcomes, the f***l microbiome, metabolites, and intestinal inflammation in dogs with tylosin-responsive enteropathy (TRE).

The double-blind, placebo-controlled clinical trial found that oral FMT was feasible and safe, with measurable but variable changes in the f***l microbiome. However, although numerically fewer relapses were observed in the FMT group during treatment, the difference was not statistically significant. Relapses occurred in both groups during follow-up, and no sustained clinical benefit was demonstrated.

The study also found no significant treatment-related effects on intestinal permeability, with no significant differences between the FMT and placebo groups.

The authors conclude that the clinical response to oral FMT was limited and inconsistent, and that no clear treatment-specific effects could be demonstrated compared with placebo. The small sample size and limited statistical power mean that these findings should be considered preliminary. Further studies are needed to investigate factors such as dosing, treatment duration and route of administration.

This study highlights the complexity of microbiome-based therapies in canine chronic enteropathy and raises an important question: can FMT become a clinically useful treatment, or do we still need to better understand which patients, doses and administration routes are most likely to benefit?

Read the full article here: https://avmajournals.avma.org/view/journals/javma/aop/javma.26.03.0178/javma.26.03.0178.xml

🐱 Happy International Cat Day! 🐱Today, FECAVA celebrates cats and highlights the importance of advancing feline health, ...
08/08/2026

🐱 Happy International Cat Day! 🐱

Today, FECAVA celebrates cats and highlights the importance of advancing feline health, welfare, and evidence-based veterinary care. 😻

Understanding feline behavior, supporting preventive healthcare, and ensuring access to high-quality veterinary medicine are essential to helping cats live healthier lives.

We recognise the dedication of companion animal veterinarians across Europe who work every day to improve feline wellbeing and strengthen the human–animal bond. 🩺🐾

Adresse

Rue Victor Oudart 7
Brussels
1030

Heures d'ouverture

Lundi 09:00 - 17:00
Mardi 09:00 - 17:00
Mercredi 09:00 - 17:00
Jeudi 09:00 - 17:00
Vendredi 09:00 - 17:00

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque FECAVA - Federation of European Companion Animal Veterinary Associations publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager